The George Institute for Global Health is thrilled to congratulate doctoral researcher Dr Lauren Heath on receiving a ...

With almost half of American adults living with high blood pressure, it makes sense that you'd want every possible tool in ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare ...

In a recent study of older patients with end-stage kidney disease living in Europe, researchers found o ne-third received an ...

Expanded indication supported by mixed bag of trial data ...

Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.

Does your blood pressure spike after a salty meal? You may be dealing with salt sensitivity, a condition in which the body ...

Filspari is now indicated for patients with focal segmental glomerulosclerosis without nephrotic syndrome to target significant proteinuria reduction.

AstraZeneca's Lokelma therapy for high potassium levels in the blood (hyperkalaemia) should see much wider usage by the NHS after becoming one of the first medicines to be assessed under NICE's raised ...

Global Phase 2 open-label clinical trial in pMN (PrisMN) enrolling, with initial data anticipated H2 2026WELLESLEY HILLS, ...

Claudins and renal adaptation to salt deficiency. Kidneys constantly filter the blood to recapture useful substances, including sodium, an essential component of salt, before they ...

Nutrition researchers have spent decades building a case for a plant that most North Americans overlook entirely. Guava ...